Tylenol® harnesses consumer insights and Kenvue’s pain and skin care expertise to launch two new pain solutions being showcased at PAINWeek Conference

August 31, 2023
Tylenol® Precise™ Pain Relieving Cream

Kenvue to introduce new topical Tylenol® Precise™ Pain Relieving Cream.

SKILLMAN, N.J. August 31, 2023 — Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced that it will showcase new topical Tylenol® Precise™ Pain Relieving Cream – the first U.S. product launch from Kenvue since it became a publicly traded company – during the PAINWeek Conference 2023 on September 5-8 at The Cosmopolitan in Las Vegas, Nevada.

Kenvue will also feature another product newly launched this year, Motrin® Dual Action with Tylenol®, a fixed combination pill (containing 250 mg of acetaminophen and 125 mg of ibuprofen in each tablet) that provides dosing that supports up to 8 hours of pain relief compared with dosing provided by Tylenol® Extra Strength or Motrin®1 single ingredient products that can provide up to 6 hours of relief.

Both of these products come in response to consumer insights collected by Tylenol®, the #1 Doctor Recommended Brand for Pain Relief.

Tylenol® Precise™

When asked what consumers would change about their topical pain relief options, nearly 40% cited the unpleasant smell and the messy, greasy, or oiliness of current available products. Insights also showed 73% of consumers who use Tylenol® orally also use topical remedies, which identified a need for the brand to develop Tylenol® Precise™.

  • Tylenol® Precise™ fits active lifestyles with a rapid-absorbing formula, fragrance-free and fresh scent options for discreet use, and a uniquely designed rollerball for hands-free, no-mess application leaving skin clear of sticky residues.
  • Both Tylenol® Precise™ formats are skincare-inspired topical creams that provide maximum-strength lidocaine (4%) without a prescription.
  • In addition, Tylenol® Precise™ Cooling Pain Relieving Cream has a light, pleasant scent so consumers can experience the dual action relief of lidocaine and menthol with an invigorating cooling sensation.
Motrin® Dual Action with Tylenol®

Motrin® Dual Action with Tylenol®, a fixed combination pill, provides dosing that supports up to 8 hours of pain relief.

Motrin® Dual Action with Tylenol®

  • By combining the strength and speed of two powerful pain relievers in one pill, Motrin® Dual Action with Tylenol® can provide a convenient alternative option for consumers.
  • Motrin ® Dual Action with Tylenol® can provide longer-lasting relief than either brand taken alone, uniting the pain-targeting strength of Motrin ® with the pain-blocking power of Tylenol®.

“With Tylenol® Precise™ we’re proud to deliver the topical formula our customers requested – one that fits their lifestyles by providing targeted pain relief both seamlessly and discreetly,” said Adam Ricciardone, Vice President, Kenvue Global Self-Care R&D2. “We’re equally excited to introduce Motrin® Dual Action with Tylenol®, which for the first time unites the power of two major pain brands in one acetaminophen-ibuprofen pill. Our ability to launch these two important products in a single year is a testament to Kenvue’s extensive global expertise in both pain relief and skin care.”

###